Baxion
Screening
Tags
Alerts
Theme
Amneal Pharmaceuticals, Inc.
AMRX
·
NASDAQ
·
$12.79
Share Price as of 11/2
·
$4B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
02/27/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K/A
Current report (amended)
10/23/26
8-K
Current report
08/10/26
8-K
Current report
08/03/26
8-K
Current report
07/31/26
8-K
Current report
07/30/26
Prospectuses and Registrations
Filter
S-3ASR
Automatic shelf registration
09/03/26
POS AM
Post-effective amendment
11/08/23
POS AM
Post-effective amendment
11/08/23
S-8 POS
Post-effective amendment (S-8)
11/08/23
S-8 POS
Post-effective amendment (S-8)
11/08/23
Proxies
Filter
DEFA14A
Additional proxy materials
07/30/26
DEFM14A
Definitive proxy (merger)
06/29/26
PREM14A
Preliminary proxy (merger)
06/18/26
DEFA14A
Additional proxy materials
04/23/26
DEFA14A
Additional proxy materials
04/22/26
Ownership
Filter
Form 4
Insider transaction
09/21/26
Form 4
Insider transaction
09/14/26
Form 4
Insider transaction
09/02/26
Form 4
Insider transaction
08/25/26
Form 4
Insider transaction
08/14/26
Other
Filter
CERT
CEO/CFO certification
12/27/23
25
Removal from listing
12/26/23
8-A12B
8-A12B
12/26/23
15-12G
Certification of termination of registration
11/20/23
EFFECT
Request for effectiveness
11/14/23
Latest Filings
Filter
8-K/A
Current report (amended)
10/23/26
S-3ASR
Automatic shelf registration
09/03/26
8-K
Current report
08/10/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/03/26
Ownership
Filter
Form 4
Insider transaction
09/21/26
Form 4
Insider transaction
09/14/26
Form 4
Insider transaction
09/02/26
Form 4
Insider transaction
08/25/26
Form 4
Insider transaction
08/14/26